These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1403495)

  • 21. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of taste-masking microcapsules containing azithromycin by fluid bed coating for powder for suspension and
    Dung PT; Trinh TD; Nguyen QH; Nguyen HM; Nguyen NC; Tran NB; Tran CS; Nguyen TH; Tung NT
    J Microencapsul; 2023 Dec; 40(5):345-356. PubMed ID: 37129865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microencapsulation of beta-galactosidase with Eudragit L-100.
    Squillante E; Morshed G; Bagchi S; Mehta KA
    J Microencapsul; 2003; 20(2):153-67. PubMed ID: 12554371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
    Khanfar MS; Salem MS; Najib NM; Pillai GK
    Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration.
    Shamma RN; Basalious EB; Shoukri RA
    Int J Pharm; 2011 Feb; 405(1-2):102-12. PubMed ID: 21145958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computation of release kinetics of isoniazid microcapsules.
    Muhuri G; Pal TK
    Boll Chim Farm; 1991 May; 130(5):169-71. PubMed ID: 1760150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of microcapsules from complex coacervation of Gantrez-gelatin. II. In vitro dissolution of nitrofurantoin microcapsules.
    Mortada SA; el Egaky AM; Motawi AM; el Khodery KA
    J Microencapsul; 1987; 4(1):23-37. PubMed ID: 3504494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation.
    Ueda M; Nakamura Y; Makita H; Kawashima Y
    J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on heart-protecting musk pH-dependent gradient-release pellets].
    Song HT; Guo T; Zhang RH; Ma Y; Li X; Bi KS
    Yao Xue Xue Bao; 2002 Oct; 37(10):812-7. PubMed ID: 12567868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microencapsulation of chloroquine diphosphate by Eudragit RS100.
    Ndesendo VM; Meixner W; Korsatko W; Korsatko-Wabnegg B
    J Microencapsul; 1996; 13(1):1-8. PubMed ID: 8903781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.
    Bando H; McGinity JW
    Int J Pharm; 2006 Apr; 313(1-2):43-8. PubMed ID: 16487672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study of acrylic resin coated gentamicin tablets for local antibiotic therapy].
    Hanamura T
    Nihon Seikeigeka Gakkai Zasshi; 1984 Jun; 58(6):555-65. PubMed ID: 6491422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.
    Kim KS; Park SJ
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):404-9. PubMed ID: 20034769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.